PARNF

Parnell Pharmaceuticals Holdings Ltd PARNF

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PARNF ACNNF CANB SILFF IWINF RCMW CBDNF ETRGF KALO PRXTF
6M 79 900.00 % -22.45 % 19.55 % 0.00 % 448.25 % -99.56 % -44.13 % -20.00 % 0.00 % -50.91 %
YTD -55.56 % 18.75 % -43.02 % 0.00 % 248.80 % -99.56 % 35.16 % -11.50 % 0.00 % -40.00 %
1Y 79 900.00 % 5.56 % -48.72 % 0.00 % -47.15 % -99.56 % 4.75 % -66.89 % 0.00 % -82.58 %
3Y 3 709.52 % -94.04 % -98.29 % -81.11 % -70.24 % -100.00 % -82.54 % -91.67 % -94.55 % -98.98 %
5Y -55.56 % -98.25 % -95.12 % -92.63 % -70.24 % -99.99 % -98.95 % -98.65 % -90.00 % -98.98 %
10Y -98.02 % -97.83 % -99.94 % -92.63 % -70.24 % -100.00 % -98.95 % -99.35 % -100.00 % -98.98 %
From the beginning -99.01 % -97.83 % -70.00 % -92.63 % -70.24 % -100.00 % -98.95 % -99.35 % -100.00 % -98.98 %

Dividend